MILLTRUST INTERNATIONAL
 

A chat with Sir David Lane on COVID-19 immunity and antibody drugs

May 11, 2020

BY Milltrust International Group

A chat with Sir David Lane on COVID-19 immunity and antibody drugs

Leading antibody expert and chief scientist of Singapore’s Agency for Science, Technology and Research, and advisor to Milltrust in Singapore, Professor Sir David Lane discusses COVID-19 immunity, antibody drugs, and the ethical and legal implications that may arise from granting ‘immunity certificates’ for travel and work.

Categories: Media News

Tags: